• Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy 

      Woan, Karrune V.; Kim, Hansol; Bjordahl, Ryan; Davis, Zachary B.; Gaidarova, Svetlana; Goulding, John; Hancock, Brian; Mahmood, Sajid; Abujarour, Ramzey; Wang, Hongbo; Tuininga, Katie; Zhang, Bin; Wu, Cheng-Ying; Kodal, Behiye; Khaw, Melissa; Bendzick, Laura; Rogers, Paul; Ge, Moyar Qing; Bonello, Greg; Meza, Miguel; Felices, Martin; Huffman, Janel; Dailey, Thomas; Lee, Tom T.; Walcheck, Bruce; Malmberg, Karl-Johan; Balzar, Bruce R.; Bryceson, Yenan; Valamehr, Bahram; Miller, Jeffrey S.; Cichocki, Frank (Journal article; Peer reviewed, 2021)
      Select subsets of immune effector cells have the greatest propensity to mediate antitumor responses. However, procuring these subsets is challenging, and cell-based immunotherapy is hampered by limited effector-cell ...